Ilan Cohn, Ph.D.
Dr. Cohn, who has a Ph.D. in biology, is the co-Founder of the Company and its Chairman. He serves on the board of directors of technology companies including life sciences in Israel and abroad. He was previously involved in the management of VC funds focused on investments in life sciences and was an advisor to management and investment committees for a number of investment firms. Dr. Cohn is a patent attorney and a co-founder and senior partner of the IP firm Cohn, De Vries, Stadler & Co. He has more than three decades of professional experience and is one of the leading IP attorneys in Israel. Widely recognized as an IP strategist, he is known for his expertise in combining IP strategy with business strategy and turning intellectual property rights, particularly patents, into first-tier, value-generating, and preserving assets.
Prof. Pnina Fishman, Ph.D.
Prof. Fishman is the Scientific Founder of the Company and was previously a professor of Life Sciences and headed the Laboratory of Clinical and Tumor Immunology at the Felsenstein Medical Research Institute, Rabin Medical Center. Prof. Fishman is a very accomplished scientist and has authored or co-authored 170 publications and presented the findings of her research at many major scientific meetings. Her scientific work was the foundation on which Can-Fite was built. This scientific work has gained recognition as one of the leading approaches for next-generation therapies for cancer and other diseases. Her past managerial experience included seven years as CEO of Mor Research Application (MRA), a company that was in charge of the commercialization of intellectual property from all hospitals and research centers of Clalit Health Services, the largest healthcare provider in Israel, and was also the first CRO in Israel. She was also involved in the establishment and served on the Board of Directors of several life sciences technology startups.
Avraham Sartani, MD
Dr. Sartani was Vice-President and Director Pharmaceutical Research and Development Division, of Recordati. Prior to joining Recordati, Dr. Sartani was at Farmitalia-carlo Erba serving in a number of roles including the Medical Director for Europe. He is a member of a number of scientific and management societies and the author/co-author of numerous publications and patents.
Mr. Goldman has served as a Director of Can-Fite since August 2017 and is a member of the Company's Audit Committee, Financial Statements Review Committee, and Compensation Committee. Mr. Goldman provides consulting services to companies in strategic-financial areas, through his wholly-owned company, Maanit-Goldman Management & Investments Ltd. He also serves as a director of Golden House Ltd, Fattal Europe (Properties) Ltd., Meitav Dash Investments Ltd., Mer Telemanagement Solutions Ltd., and IceCure Medical Ltd. Mr. Goldman served as the Professional Secretary of the Peer Review Institute of the Certified Public Accountants Institute in Israel from October 2004 until September 2008. Mr. Goldman previously worked for Kesselman & Kesselman (Israeli member firm of PricewaterhouseCoopers) for 19 years, serving as partner and then senior partner. He has also served as Managing Director of Argoquest Holdings, LLC and acted as a consultant to a private equity initiative with Poalim Capital Markets & Investments Ltd. Mr. Goldman holds a B.A. degree in Economics and Accounting from Tel Aviv University and is a Certified Public Accountant (Israel).
Mr. Regev has over thirteen years of experience in accounting, financial management and control and general management of commercial enterprises. He has served on Can-Fite's Board of Directors since July 2011 and has served as a member of the Audit Committee and Compensation Committee since February 2014. Mr. Regev is currently the Chief Executive Officer of Gaon Holdings Ltd, a publicly traded Israeli holding company traded on the TASE which focuses on three areas of operation - Cleantech / Water, Financial Services, Retail/Trading. Mr. Regev is currently also the Chief Executive Officer of Middle East Tube Company Ltd a publicly traded Israeli company traded on the TASE which focuses on steel pipe manufacturing and galvanization services. Mr. Regev was the Chief Executive Officer of Shaked Global Group Ltd, a privately-held equity investment firm that provides value-added capital to environmental-related companies and technologies. Prior to joining Shaked, from 2001 to 2008, Mr. Regev was Vice President of Commercial Business at Housing & Construction Holding, or HCH, Israel's largest infrastructure company. Mr. Regev holds an LLB degree in Law (Israel) and is a licensed attorney and has been a licensed CPA since 1999.
During the past 35 years, Mr. Bornstein has played key roles in the Israeli biomed industry. He was the General Manager of Bristol-Myers Squibb (Israel). Mr. Bornstein is the CEO and the founder of Shizim group, a life science holding company. He is the Founder of ShizimXL, international Medical Devices & ShizimVS, Digital Health innovation centers. He is the Chairman of GCP Clinical Studies Ltd., one of the top providers of clinical research services and educational programs in Israel. He served as the Biotechnology Committee Chairman of the United States-Israel Science & Technology Commission (the "USISTC”). Mr. Bornstein is the founder of ILSI - Israel Life Science Industry Organization and Founder of ITTN - Israel Tech Transfer Organization. He is a Co-Founder and Director of Microbot Medical (NASDAQ: MBOT) and a Director of XACT Robotics.